Minister for Health Simon Harris TD has launched a new evidence based National Clinical Guideline (No.19) to assist healthcare professionals with the diagnosis, staging and treatment of patients with oesophageal or oesophagogastric junction cancer. 

The guideline can be viewed on the NCCP and NCEC websites.

Cancer continues to be a major healthcare challenge worldwide. Ireland has one of the highest rates of oesophageal cancer in Europe with rates of 7.9 per 100,000, with the rate projected to rise. The National Cancer Strategy places a focus on prevention, early diagnosis, treatment and quality of life.  The development and implementation of National Clinical Guidelines, related to cancer care, are underpinned by recommendation 37 in the National Cancer Strategy 2017 – 2026.

The guideline was developed by a multidisciplinary group, supported by the HSE’s National Cancer Control Programme (NCCP) and quality assured by the Department of Health’s National Clinical Effectiveness Committee (NCEC) and was chaired by Professor John Reynolds, Consultant Upper GI surgeon, St James’s Hospital, Dublin.

The guideline will be updated on a three yearly basis to reflect the changing evidence base and can be viewed on the NCCP and NCEC websites.